| 摘要 |
FIELD: chemistry. ^ SUBSTANCE: application of lornooxycam and enol ethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridil)-2H-thieno[3,2-e]-1,2-thiazin-3-carboxylic acid amide-1,1-dioxide (including 6-chloro-4-(1-(ethoxycarbamoyloxy)ethoxy)-2-methyl-N-(2-pyridil)-2H-thieno [2,3-e]-1,2-thiazin-3-carboxylic acid amide-1,1-dioxide) is proposed for pharmaceutical composition obtaining used at prevention or treatment of Alzheimer disease ( AD) or arteriosclerosis. ^ EFFECT: lornooxycam decrease the A-42/A-40 level (efficiency parametre of Alzheimer disease treatment), has low side effects in combination with high treatment efficiency parametre in comparison with other means ^ 3 cl, 7 dwg, 1 ex |
